Back to Browse Journals

Advances and Applications in Bioinformatics and Chemistry

Dr Fernandez-Recio

IRB research programme in Computational Biology, Barcelona Supercomputing Center, Spain

Dr Fernandez-Recio

Editor-in-Chief: Juan Fernandez-Recio

Dr Fernández-Recio is leading the Protein Interactions and Docking group at the Life Sciences Department of the Barcelona Supercomputing Center. During his PhD thesis research in Biochemistry at the University of Zaragoza (Spain), supervised by Prof Carlos Gómez-Moreno and Prof Javier Sancho, he characterized the biophysical role of specific residue interactions in protein folding and stability. As a research associate with Prof Ruben Abagyan at the Scripps Research Institute in California, he developed innovative computational tools for the structural prediction and characterization of protein–protein complexes. As a Marie Curie Research Fellow within the group of Prof Sir Tom Blundell at the University of Cambridge in UK, he developed highly efficient docking schemes, combining theoretical energy considerations and data-driven scoring, and provided computational models for a number of protein–protein complexes as well as new insights on the protein association mechanism.

Dr Fernández-Recio's past research at the Barcelona Supercomputing Center has been devoted to the theoretical study of biological phenomena at molecular level and the development of novel computer tools for the structural prediction and characterization of protein–protein and protein–RNA interactions. He devised innovative methods for the prediction of hot-spot residues or protein-nucleic acid interfaces, and has been actively involved in multi-disciplinary collaborations for the study of systems of biomedical interest, like the interaction between polygalactorunase and its inhibitor, the nucleic acid binding properties of translin, or the dynamics of oligomerization of diverse systems by SAXS. His current research includes the application of high-performance computing techniques to current challenges in docking, such as modeling of flexible complexes, interactomics, or drug discovery targeting protein–protein interactions.

Dr Fernández-Recio has been an active participant in the CAPRI communitywide experiment for the evaluation of protein–protein docking methods since it started in 2001. At national and international levels, he has served as evaluator of multiple grant agencies and has acted as reviewer, guest editor, and member of the editorial advisory boards in many different scientific journals.

Editorial Board

Ruben Abagyan, Professor, University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences, San Diego Supercomputer Center, La Jolla, CA, USA

Ibon Alkorta, Instituto de Quimica Medica (CSIC), Madrid, Spain

Johan Aqvist, Professor, Department of Molecular Biology, Uppsala University, Uppsala, Sweden

Diego Bonatto, Professor, Universidade de Caxias do Sul (UCS), Laboratório de Genética Toxicológica, Instituto de Biotecnologia, Centro de Ciências Biológicas e da Saúde, Rio Grande do Sul, Brazil

Jim Briggs, Department of Biology and Biochemistry, University of Houston, Houston, USA

Claudio Cavasotto, Biomedicine Research Institute of Buenos Aires - CONICET - Partner Institute of the Max Planck Society, Buenos Aires, Argentina

Marta Filizola, PhD, Professor, Department of Pharmacological Sciences, Dean of the Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Paul Horton, Senior Researcher, Artificial Intelligence Research Center, AIST and Visiting Associate Professor, University of Tokyo, Japan

Alexander MacKerell, Grollmann-Glick Professor of Pharmaceutical Sciences, Computer-Aided Drug Design Center, Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA

Bernard Maigret, CNRS Research Director, Nancy-University, France

Campbell McInnes, Pharmaceutical and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA

Maria A. Miteva, Research Director at Inserm, Molecules Therapeutiques in Silico, Inserm U973 - University Paris Diderot, Paris, France

Kenji Mizuguchi, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

Hiromi Nishida, Professor, Applied Bioinformatics, Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Japan

Hongmao Sun, National Center for Advancing Translational Sciences (NCATS), Bethseda, MD, USA

Max Totrov, Molsoft LLC, La Jolla, CA, USA

Ilya Vakser, Director and Professor, Center for Computational Biology, The University of Kansas, Lawrence, KS, USA

Alexandre Varnek, Professor, Faculty of Chemistry, University of Strasbourg, Strasbourg, France

Chandra Verma, Bioinformatics Institute (A-STAR), National University of Singapore, Nanyang Technological University, Singapore

Hugo O Villar, Director, Life Sciences Programs, University of California, San Diego, La Jolla, CA, USA

Bruno Villoutreix, Founding Editor, Director of Research at the Inserm Institute, University of Paris 5 and the University Paris Diderot - Paris 7, France

Rebecca Wade, Molecular and Cellular Modeling Group, Heidelberg > Institute for Theoretical Studies (HITS) and Zentrum für Molekulare > Biologie der Universität Heidelberg (ZMBH), Heidelberg, Germany

Anders Wallqvist, Deputy Director, Biotechnology HPC Software Applications Institute, Telemedicine and Advanced Technology Research Center, US Army Medical Research and Materiel Command, Fort Detrick, MD, USA

Jim Warwicker, Senior Lecturer, Faculty of Life Sciences, University of Manchester, Manchester, UK

Yang Zhang, Center for Computational Medicine and Bioinformatics, The University of Michigan, MI, USA